Tamoxifen is an antioestrogen widely used in the breast cancer treatment. Its paradoxical antioestrogenic action on breast and its oestrogenic action on the endometer is well-known. Since 1988, few cases of malignant mixed müllerian tumors following tamoxifen were described. We report a new case of uterine malignant mixed müllerian tumor four years after the end of tamoxifen for breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.gyobfe.2007.06.020 | DOI Listing |
Publication Analysis
Top Keywords
mixed müllerian
12
breast cancer
12
müllerian tumor
8
tamoxifen breast
8
malignant mixed
8
[malignant mixed
4
tumor uterus
4
tamoxifen
4
uterus tamoxifen
4
breast
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!